Journal article

Role of the cholinergic system in the pathology and treatment of schizophrenia

E Scarr, B Dean

Expert Review of Neurotherapeutics | Published : 2009

Abstract

Schizophrenia is a devastating psychiatric disorder; the diagnosis probably encompasses a number of illnesses with similar clinical presentations, complicating both treatment and studies into the pathology of the disorder. The development of antipsychotic medications revolutionized treatment for the disorder. However, there are still symptom domains that are relatively untouched by the drugs currently available; these are the cognitive deficits and the negative symptoms. Basic research strongly supports a role of acetylcholine in cognitive processes, making it a primary target for drugs designed to improve this most impairing symptom. In addition, the fact that acetylcholine can modulate dop..

View full abstract

Related Projects (1)

Grants

Awarded by National Institutes of Health


Funding Acknowledgements

Elizabeth Scarr is the Royce Abbey Postdoctoral Research Fellow, funded by Australian Rotary Health Research Fund. Brian Dean is a NH&MRC (Australia) Senior Research Fellow (#400016). This work was supported in part by NHMRC Project Grant #114253, NIMH Grant # MH069691-01A1 and The Rebecca L Cooper Medical Research Foundation.